Kremer JM - Search Results

1

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.

Genovese MC, Kremer JM, Kartman CE, Schlichting DE, Xie L, Carmack T, Pantojas C, Sanchez Burson J, Tony HP, Macias WL, Rooney TP, Smolen JS. Genovese MC, et al. Among authors: kremer jm. Rheumatology (Oxford). 2018 May 1;57(5):900-908. doi: 10.1093/rheumatology/kex489. Rheumatology (Oxford). 2018. PMID: 29415145 Free PMC article. Clinical Trial.

2

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.

Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R. Weinblatt ME, et al. Among authors: kremer jm. J Rheumatol. 1992 Oct;19(10):1537-41. J Rheumatol. 1992. PMID: 1334515 Clinical Trial.

3

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.

Kremer JM, Phelps CT. Kremer JM, et al. Arthritis Rheum. 1992 Feb;35(2):138-45. doi: 10.1002/art.1780350203. Arthritis Rheum. 1992. PMID: 1734902

4

Clinical studies of omega-3 fatty acid supplementation in patients who have rheumatoid arthritis.

Kremer JM. Kremer JM. Rheum Dis Clin North Am. 1991 May;17(2):391-402. Rheum Dis Clin North Am. 1991. PMID: 1862247 Review.

5

Methotrexate therapy in the treatment of rheumatoid arthritis.

Kremer JM. Kremer JM. Rheum Dis Clin North Am. 1989 Aug;15(3):533-56. Rheum Dis Clin North Am. 1989. PMID: 2672136 Review.

6

Methotrexate 1989--the evolving story.

Kremer JM. Kremer JM. J Rheumatol. 1989 Mar;16(3):261-3. J Rheumatol. 1989. PMID: 2724244 No abstract available.

7

Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.

Kremer JM, Petrillo GF, Hamilton RA. Kremer JM, et al. J Rheumatol. 1995 Jan;22(1):38-40. J Rheumatol. 1995. PMID: 7699678 Clinical Trial.

8

Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.

Kremer JM, Petrillo GF, Hamilton RA. Kremer JM, et al. J Rheumatol. 1995 Jan;22(1):41-4. J Rheumatol. 1995. PMID: 7699679 Clinical Trial.

9

Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study.

Kremer JM, Davies JM, Rynes RI, Fink S, Lawrence DA, Petrillo GF, Mullaly PM. Kremer JM, et al. Arthritis Rheum. 1995 May;38(5):601-7. doi: 10.1002/art.1780380504. Arthritis Rheum. 1995. PMID: 7748214 Clinical Trial.

10

Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis.

Kremer JM. Kremer JM. Br J Rheumatol. 1995 Nov;34 Suppl 2:26-9. Br J Rheumatol. 1995. PMID: 8535645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters